[Hematopoietic stem cell transplantation for hematological malignancies].
OBJECTIVE
To evaluate the efficacy of hematopoietic stem cell transplantation (HSCT) in hematological malignancies.


METHODS
Twenty-five patients with hematological malignancies were treated by autologous bone marrow transplantation (ABMT), autologous peripheral blood stem cell transplantation (APB-SCT) or Allo-PBSCT. Eight acute myeloid leuekmia (AML) patients who received autologous hematopoietic stem cell transplantation (AHSCT) were treated by chemotherapy again.


RESULTS
All the patients engrafted gained hematopoietic reconstitution; they were followed up for 6 to 91 months; five patients died; twenty patients were alive in a disease-free situation.


CONCLUSIONS
After the patients with acute leukemia receive AHSCT, the relapse incidences can be reduced obviously by regular chemotherapy. HSCT is one of the best methods for hematological malignancies.
Zhong
Mei-zuo
MZ
Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
Chen
Fang-ping
FP
Shu
Yi-gang
YG
D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D019337:Hematologic Neoplasms / Q000601:surgery*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D008228:Lymphoma, Non-Hodgkin / Q000601:surgery; D008297:Male; D008875:Middle Aged